Autogenic Inhibition Versus Reciprocal Inhibition Muscle Energy Techniques in Iliotibial Band Syndrome

Comparison of Effects of Autogenic Inhibition and Reciprocal Inhibition Muscle Energy Techniques on Iliotibial Band Syndrome

Comparison of effects of autogenic inhibition and reciprocal inhibition muscle energy techniques on iliotibial band syndrome

Study Overview

• Status: Recruiting
• Conditions: Iliotibial Band Syndrome
• Intervention / Treatment: Procedure: Autogenic Inhibition (AI) MET (Post Facilitation Stretch); Procedure: Reciprocal Inhibition (RI) MET

Detailed Description

A single-blinded randomized control trial will be conducted over a period of one year in Foundation University Islamabad. Forty participants will be assigned to two groups: Group A (AI) and Group B (RI), with 20 participants each. The AI technique will involve a maximal isometric contraction of the target muscle followed by a stretch, while the RI technique will involve a maximal isometric contraction of the antagonist muscle followed by a similar stretching protocol. Both groups will perform the exercises 3 times per week for 2 weeks. Pain, Hip range of motion (ROM) and lower extremity function will be assessed using Numeric Pain Rating Scale (NPRS), goniometer and Lower Extremity Functional Scale (LEFS) respectively.

The outcomes will be measured in terms of improvements in pain score (NPRS), hip range of motion (ROM), and overall lower extremity function.

• Study Type: Interventional
• Enrollment (Estimated): 40
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Rida Ishtiaq, MS-MSKPT*; Phone Number: 03365530415; Email: ridaishtiaq777@gmail.com

Study Locations

• Pakistan
  • Punjab
    • Rawalpindi, Punjab, Pakistan, 46000
      • Recruiting
      • Foundation University College of Physcial Therapy
      • Contact: Furqan Yaqoob, OMPT,PHD*; Phone Number: 03465333101; Email: furqan.yaqoob@fui.edu.pk

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria

• Both male and female participants
• Age : 19-45years (8)
• Lateral knee pain (>3 months)
• Tenderness over lateral femoral condyle
• Positive Flexibility Tests
• Modified Ober's test (9)
• Length assessment of Tensor Fasciae Latae and Iliotibial Band (10)
• Positive Pain Provocation Tests
• Renne's test
• Noble's Compression test (11) *(individuals with 3 positive tests out of above mentioned 4 tests will be included)

Exclusion Criteria

• Recent lower limb or pelvic girdle surgery within the past 3 months
• Lower limb fractures or trauma within the past year.
• Multiple lower limb surgeries (>2)
• Presence of any structural or postural disorders (kyphosis or severe scoliosis)
• Neurological disorders
• Hip and knee Osteoarthritis
• Rheumatoid Arthritis
• Pregnancy

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Autogenic Inhibition (AI) MET Group; Autogenic Inhibition (AI) MET (Post Facilitation Stretch); The shortened muscle (Tensor Fascia Latae) is placed in a mid-range position about halfway between a fully stretched and a fully relaxed state.; The patient contracts the muscle isometrically, using a maximum degree of effort for 5-10 seconds while the effort is resisted completely.; On release of the effort, a rapid stretch is made to a new barrier, without any 'bounce', and this is held for at least 10 seconds.; The patient relaxes for approximately 20 seconds and the procedure is repeated between three and five times more.	Procedure: Autogenic Inhibition (AI) MET (Post Facilitation Stretch); Autogenic Inhibition (AI) MET (Post Facilitation Stretch); The shortened muscle (Tensor Fascia Latae) is placed in a mid-range position about halfway between a fully stretched and a fully relaxed state.; The patient contracts the muscle isometrically, using a maximum degree of effort for 5-10 seconds while the effort is resisted completely.; On release of the effort, a rapid stretch is made to a new barrier, without any 'bounce', and this is held for at least 10 seconds.; The patient relaxes for approximately 20 seconds and the procedure is repeated between three and five times more.
Experimental: Reciprocal Inhibition (RI) MET Group; Reciprocal Inhibition (RI) MET; The shortened muscle (Tensor Fascia Latae) is placed in a mid-range position about halfway between a fully stretched and a fully relaxed state.; The patient contracts the antagonist muscles (hip adductors), using a maximum degree of effort for 5-10 seconds while the effort is resisted completely.; On release of the effort, a rapid stretch to TFL is made to a new barrier, without any 'bounce', and this is held for at least 10 seconds.; The patient relaxes for approximately 20 seconds and the procedure is repeated between three and five times more.	Procedure: Reciprocal Inhibition (RI) MET; Reciprocal Inhibition (RI) MET; The shortened muscle (Tensor Fascia Latae) is placed in a mid-range position about halfway between a fully stretched and a fully relaxed state.; The patient contracts the antagonist muscles (hip adductors), using a maximum degree of effort for 5-10 seconds while the effort is resisted completely.; On release of the effort, a rapid stretch to TFL is made to a new barrier, without any 'bounce', and this is held for at least 10 seconds.; The patient relaxes for approximately 20 seconds and the procedure is repeated between three and five times more.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pain severity	Pain will be assessed using Numeric Pain Rating Scale (NPRS),	2 weeks
Range of motion	Hip range of motion (ROM) will be assessed using goniometer	2 weeks
Functional status of lower limb	Lower extremity function will be assessed using Lower Extremity Functional Scale (LEFS)	2 weeks

Collaborators and Investigators

• Sponsor: Foundation University Islamabad

Study record dates

Study Major Dates

• Study Start (Actual): July 15, 2024
• Primary Completion (Estimated): June 15, 2025
• Study Completion (Estimated): July 15, 2025

Study Registration Dates

• First Submitted: March 4, 2025
• First Submitted That Met QC Criteria: March 4, 2025
• First Posted (Actual): March 25, 2025

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: March 4, 2025
• Last Verified: March 1, 2025

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Wounds and Injuries; Pathologic Processes; Disease; Leg Injuries; Knee Injuries; Cumulative Trauma Disorders; Sprains and Strains; Syndrome; Iliotibial Band Syndrome
• Other Study ID Numbers: FUI/CTR/2025/3

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No